Literature DB >> 8440029

Nomenclature of amyloid and amyloidosis. WHO-IUIS Nomenclature Sub-Committee.

.   

Abstract

This classification of amyloid and amyloidosis is based on the amyloid fibril proteins, followed by a designation of the fibril protein precursor. Additional information includes the protein type or variant (where applicable) and the clinical diagnosis.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8440029      PMCID： PMC2393434     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN： 0042-9686            Impact factor:   9.408


  27 in total

1.  The single proline-glutamine substitution at position 5 enhances the potency of amyloid fibril formation of murine apo A-II.

Authors:  K Higuchi; T Yonezu; S Tsunasawa; F Sakiyama; T Takeda
Journal:  FEBS Lett       Date:  1986-10-20       Impact factor: 4.124

2.  Unique amyloid protein subunit common to different types of amyloid fibril.

Authors:  G Husby; J B Natvig; T E Michaelsen; K Sletten; H Höst
Journal:  Nature       Date:  1973-08-10       Impact factor: 49.962

3.  Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein.

Authors:  G G Glenner; C W Wong
Journal:  Biochem Biophys Res Commun       Date:  1984-05-16       Impact factor: 3.575

4.  Identification of amyloid A protein in a sporadic Muckle-Wells syndrome. N-terminal amino acid sequence after isolation from formalin-fixed tissue.

Authors:  R P Linke; K L Heilmann; W B Nathrath; M Eulitz
Journal:  Lab Invest       Date:  1983-06       Impact factor: 5.662

5.  Purification and structural studies of a major scrapie prion protein.

Authors:  S B Prusiner; D F Groth; D C Bolton; S B Kent; L E Hood
Journal:  Cell       Date:  1984-08       Impact factor: 41.582

6.  A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas.

Authors:  P Westermark; C Wernstedt; E Wilander; K Sletten
Journal:  Biochem Biophys Res Commun       Date:  1986-11-14       Impact factor: 3.575

7.  Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type).

Authors:  S Tawara; M Nakazato; K Kangawa; H Matsuo; S Araki
Journal:  Biochem Biophys Res Commun       Date:  1983-11-15       Impact factor: 3.575

8.  Beta-2 microglobulin is an amyloidogenic protein in man.

Authors:  P D Gorevic; T T Casey; W J Stone; C R DiRaimondo; F C Prelli; B Frangione
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

9.  Amyloid fibrils in hereditary cerebral hemorrhage with amyloidosis of Icelandic type is a variant of gamma-trace basic protein (cystatin C).

Authors:  J Ghiso; O Jensson; B Frangione
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

10.  Variant apolipoprotein AI as a major constituent of a human hereditary amyloid.

Authors:  W C Nichols; F E Dwulet; J Liepnieks; M D Benson
Journal:  Biochem Biophys Res Commun       Date:  1988-10-31       Impact factor: 3.575
View more
  20 in total

Review 1.  Respiratory Tract Amyloidosis. State-of-the-Art Review with a Focus on Pulmonary Involvement.

Authors:  Renata Rocha de Almeida; Gláucia Zanetti; Jorge Luiz Pereira E Silva; Cesar Augusto Araujo Neto; Antônio Carlos Portugal Gomes; Gustavo de Souza Portes Meirelles; Thiago Krieger Bento da Silva; Luiz Felipe Nobre; Bruno Hochhegger; Dante Luiz Escuissato; Edson Marchiori
Journal:  Lung       Date:  2015-08-27       Impact factor: 2.584

2.  [Amyloid diagnostics in rheumatic diseases].

Authors:  C Röcken; J Ernst
Journal:  Pathologe       Date:  2006-11       Impact factor: 1.011

Review 3.  [Amyloidosis of the heart].

Authors:  A V Kristen; C Röcken
Journal:  Pathologe       Date:  2012-05       Impact factor: 1.011

4.  [Amyloidoses in the Berlin Museum of Medical History of the Charité].

Authors:  C Röcken; N Widulin; T Schnalke
Journal:  Pathologe       Date:  2009-05       Impact factor: 1.011

Review 5.  [Amyloid and amyloidoses].

Authors:  C Röcken; M Eriksson
Journal:  Pathologe       Date:  2009-05       Impact factor: 1.011

Review 6.  [Update on immunohistological classification of amyloidoses].

Authors:  C Röcken
Journal:  Pathologe       Date:  2009-12       Impact factor: 1.011

Review 7.  Anti-amyloid drugs: potential in the treatment of diseases associated with aging.

Authors:  R Kisilevsky
Journal:  Drugs Aging       Date:  1996-02       Impact factor: 3.923

8.  Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain.

Authors:  A D Snow; R T Sekiguchi; D Nochlin; R N Kalaria; K Kimata
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

9.  Localized thymic amyloidosis presenting with myasthenia gravis: case report.

Authors:  Seung-Myoung Son; Yong-Moon Lee; Si Wook Kim; Ok-Jun Lee
Journal:  J Korean Med Sci       Date:  2013-12-26       Impact factor: 2.153

Review 10.  The multiple mechanisms of amyloid deposition: the role of parkin.

Authors:  Maria A Mena; José A Rodríguez-Navarro; Justo García de Yébenes
Journal:  Prion       Date:  2009-01-09       Impact factor: 3.931
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.